1. Olusanya BO, Kaplan M, Hansen TWR. Neonatal hyperbilirubinaemia: a global perspective. Lancet Child Adolesc Health. 2018 Aug;2(8):610–20.
2. Lai NM, Lee SWHWH, Wai SX, Teh ZW, Chan MY, Yin Sear YS, et al. The choice of population and outcomes in neonatal trials on hyperbilirubinaemia: are they relevant? An analysis of Cochrane neonatal reviews. Neonatology. 2020.
3. Bhutani VK, Johnson LH, Jeffrey Maisels M, Newman TB, Phibbs C, Stark AR, et al. Kernicterus: epidemiological strategies for its prevention through systems-based approaches. J Perinatol. 2004 Oct;24(10):650–62.
4. Johnson L, Bhutani VK, Karp K, Sivieri EM, Shapiro SM. Clinical report from the pilot USA Kernicterus Registry (1992 to 2004). J Perinatol. 2009 Feb;29(Suppl 1):S25–45.
5. Alkén J, Håkansson S, Ekéus C, Gustafson P, Norman M. Rates of extreme neonatal hyperbilirubinemia and kernicterus in children and adherence to national guidelines for screening, diagnosis, and treatment in Sweden. JAMA Netw Open. 2019 Mar 1;2(3):e190858.